Back
ACADIA Pharmaceuticals Vs. Supernus Pharmaceuticals Industry Stock Comparison
Sell
38
ACAD
ACADIA Pharmaceuticals
Last Price:
14.82
Seasonality Move:
14.68%
Sell
41
SUPN
Supernus Pharmaceuticals
Last Price:
33.98
Seasonality Move:
6.84%
Sell
38
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $14.57. The Score for ACAD is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $34.07. The Score for SUPN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $14.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACAD is experiencing slight selling pressure.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $34.07
The current trend is moderately bullish and SUPN is experiencing selling pressure, which indicates risk of future bearish movement.
ACAD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 42.57 | Sell |
| Chaikin Money Flow: | -213833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.5 - 15.22) | Sell |
| Bollinger Bands (100): | (14.77 - 17.37) | Sell |
SUPN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.58 | Buy |
| Relative Strength Index (14 RSI): | 57.24 | Buy |
| Chaikin Money Flow: | -328276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.8 - 34.14) | Buy |
| Bollinger Bands (100): | (28.07 - 33.95) | Buy |
ACAD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.56 | Buy |
| 20-day SMA: | 14.73 | Sell |
| 50-day SMA: | 15.47 | Sell |
| 200-day SMA: | 18.12 | Sell |
| 8-day EMA: | 14.66 | Sell |
| 20-day EMA: | 14.84 | Sell |
| 50-day EMA: | 15.37 | Sell |
| 200-day EMA: | 17.76 | Sell |
SUPN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.11 | Sell |
| 20-day SMA: | 33.37 | Buy |
| 50-day SMA: | 33.05 | Buy |
| 200-day SMA: | 30.46 | Buy |
| 8-day EMA: | 34.12 | Sell |
| 20-day EMA: | 33.53 | Buy |
| 50-day EMA: | 32.72 | Buy |
| 200-day EMA: | 30.96 | Buy |
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $0.29 per share.
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
ACADIA Pharmaceuticals Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Supernus Pharmaceuticals Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||